BC Innovations | Jan 28, 2010
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Cyclin-dependent kinase 4 (CDK4); microRNA-26a (miR-26a) A study in mice and in humans suggests that miR-26a could be a useful biomarker for aggressive...
BC Innovations | Jul 9, 2009
Targets & Mechanisms

Tumor-suppressing miRNAs

A team of U.S. researchers has identified a microRNA that could play a role as a tumor suppressor in hepatocellular carcinoma. 1 The molecule significantly reduced tumor burden in murine liver cancer models, but delivery...
BC Innovations | Jun 18, 2009
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Brain cancer MicroRNA-26a (miRNA-26a); phosphatase and tensin homolog deleted on chromosome ten (PTEN; MMAC1; TEP1); protein kinase B (PKB; Akt) Studies in primary tumor...
BC Innovations | Sep 11, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Lymphoma Cellular myelocytomatosis oncogene (c-MYC); enhancer of zeste homolog 2 (Drosophila) (EZH2); MicroRNA-26a (miRNA-26a) Studies in murine and human cell...
Items per page:
1 - 4 of 4